Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

Fig. 5

All Pairwise Difference in Predicted Mean Progression-Free Survival Times for Nonsquamous, EGFR Mutation Negative, PD-L1 <  5%. Notes: Differences defined as row treatment minus column treatment with 95% Credible Intervals and probability of significant difference. Colors represent a “heat map” with blues representing large negative differences, increasing through to dark reds for large positive mean differences

Back to article page